”
TITLE
Efficacy and Safety of Repetitive Transcranial Magnetic Stimulation Using an H1-coil or Figure-8-coil in the Treatment of Unipolar Major Depressive Disorder: A Study Protocol for a Randomized Controlled Trial
AUTHORS
Filipcic I; Simunovic Filipcic I; Gajsak T; Milovac Z; Sucic S; Ivezic E; Zecevic Penic S; Orgulan I; Sebo D; Jelec V; Bajic Z.
SOURCE
Psychiatria Danubina. 30(1):41-46, 2018 Mar.
ABSTRACT
Repetitive transcranial magnetic stimulation (rTMS) is a noninvasive technique with few side effects that has been reported to be effective in the treatment of major depressive disorder (MDD). At present, no randomized controlled trials (RCT) have compared the efficacy and safety of rTMS delivered by the figure-8-coil and the H1-coil. We describe an industry-independent, randomized, controlled, single-blinded, single-center study protocol assessing the differences in efficacy and safety of rTMS for patients diagnosed with MDD with the H1-coil and figure-8-coil as an add-on to stable pharmacotherapy or pharmacotherapy alone. Stimulation protocols follow those that led to the FDA clearance of these treatments for MDD. The sample of 76 patIents in each of the three groups will be enrolled and assessed with clinical and neuropsychological tests. The primary outcome is remission rate defined as Hamilton depression rating scale (HAM-D17) score <=7 at the end of week-4. This clinical trial will address the efficacy and safety of rTMS modalities for MDD. The evaluation of biological markers will also help to elucidate the pathophysiology of MDD and the mechanisms of action of rTMS.
“
